InMed Pharmaceuticals Inc. (INM) M&A Call Prepared Remarks Transcript
InMed Pharmaceuticals Inc. recently held a conference call to discuss its merger agreement with Mentari Therapeutics. The call featured key executives who provided insights into the merger's potential outcomes and future business plans. Attendees were reminded that the discussion may include forward-looking statements regarding clinical development timelines.
- ▪InMed Pharmaceuticals is merging with Mentari Therapeutics.
- ▪The conference call took place on May 19, 2026.
- ▪Key executives participated in the call to discuss the merger's implications.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4908604-inmed-pharmaceuticals-inc-inm-m-and-a-call-prepared-remarks-transcript"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
